Diplomat's Kelly Procailo Receives BCOP Certification
The nation's largest independent specialty pharmacy is proud to announce Kelly Procailo's certification of BPS Board Certified Oncology Pharmacist.
Get Alerts DPLO Hot Sheet
Join SI Premium – FREE
FLINT, Mich., July 6, 2016 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that Kelly Procailo, PharmD, has received the Board of Pharmacy Specialties (BPS) Board Certified Oncology Pharmacist (BCOP) certification.
To learn more about Diplomat's oncology program, click here.
BCOP certified pharmacists are increasingly recognized for their specialized training, knowledge, and skills in oncology practice. This is critical given the increasing number and complexity of drug therapies for oncology patients and the future drug pipeline. Procailo is one of about 1,900 oncology pharmacists in the nation who hold this certification.
Procailo is the clinical oncology manager within the Clinical Services Department at Diplomat. She maintains therapeutic and medication protocols/decision tools, drives policy and procedural development, and provides clinical support for all oncology initiatives.
"We are proud of Dr. Procailo's accomplishment," said Gary Rice, senior vice president of Clinical Services, Education and Human Resources at Diplomat. "She brings additional knowledge and experience to the Diplomat oncology team that will ultimately improve patient care initiatives and programs."
Procailo began her career at the University of Michigan Health System (UMHS) as an infusion staff pharmacist. During her six-plus years at UMHS, she served with the anemia management program, the oral oncolytic program and the cancer center orders team, then served as the lead infusion pharmacist for the health system's cancer center, overseeing operations.
Procailo serves on the University of Michigan College of Pharmacy Board of Governors and is a member of the Hematology and Oncology Pharmacists Association and the American Society of Clinical Oncology.
About Diplomat
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
CONTACT:Kali Lucas, Public Relations Coordinator 810.768.9580 | [email protected]
Logo - http://photos.prnewswire.com/prnh/20140928/148820
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomats-kelly-procailo-receives-bcop-certification-300294750.html
SOURCE Diplomat Pharmacy, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Belden completes acquisition of Ruckus Networks from Vistance
- U.S. Army Four-Star General Gustave F. Perna Joins Exiger as Strategic Advisor
- Momentum Cyber Mid-Year 2026 Review: Cybersecurity M&A on Track for Highest Deal Count Ever Tracked
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share